Applied DNA Sciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Applied DNA Sciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Life Sciences earnings growth | 17.2% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 22 Aug 2024 |
Recent future growth updates
Recent updates
The Market Doesn't Like What It Sees From Applied DNA Sciences, Inc.'s (NASDAQ:APDN) Revenues Yet As Shares Tumble 26%
Dec 20
Is Applied DNA Sciences (NASDAQ:APDN) In A Good Position To Invest In Growth?
Jan 01Applied DNA climbs 51% after winning large purchase order
Oct 10Applied DNA stock rises 12% on launching monkeypox testing service in New York
Sep 06Applied DNA adds 17% as company seeks approval for monkeypox test in New York
Aug 19Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2025 | 5 | -13 | N/A | N/A | 2 |
| 9/30/2024 | 3 | -7 | -14 | -14 | N/A |
| 6/30/2024 | 3 | -8 | -14 | -13 | N/A |
| 3/31/2024 | 6 | -13 | -12 | -11 | N/A |
| 12/31/2023 | 9 | -7 | -9 | -8 | N/A |
| 9/30/2023 | 13 | -10 | -7 | -6 | N/A |
| 6/30/2023 | 16 | -7 | -7 | -7 | N/A |
| 3/31/2023 | 18 | -5 | -8 | -7 | N/A |
| 12/31/2022 | 19 | -7 | -8 | -8 | N/A |
| 9/30/2022 | 18 | -8 | -9 | -9 | N/A |
| 6/30/2022 | 18 | -12 | -12 | -10 | N/A |
| 3/31/2022 | 15 | -15 | -12 | -10 | N/A |
| 12/31/2021 | 12 | -14 | -15 | -13 | N/A |
| 9/30/2021 | 9 | -14 | -16 | -13 | N/A |
| 6/30/2021 | 6 | -14 | -14 | -12 | N/A |
| 3/31/2021 | 5 | -14 | -16 | -13 | N/A |
| 12/31/2020 | 3 | -15 | -14 | -13 | N/A |
| 9/30/2020 | 2 | -13 | -12 | -11 | N/A |
| 6/30/2020 | 3 | -10 | -10 | -10 | N/A |
| 3/31/2020 | 5 | -9 | -8 | -8 | N/A |
| 12/31/2019 | 5 | -8 | -8 | -8 | N/A |
| 9/30/2019 | 5 | -9 | -7 | -7 | N/A |
| 6/30/2019 | 5 | -11 | -8 | -8 | N/A |
| 3/31/2019 | 4 | -12 | -8 | -7 | N/A |
| 12/31/2018 | 4 | -12 | -6 | -6 | N/A |
| 9/30/2018 | 4 | -12 | -7 | -7 | N/A |
| 6/30/2018 | 4 | -11 | N/A | -5 | N/A |
| 3/31/2018 | 5 | -11 | N/A | -6 | N/A |
| 12/31/2017 | 4 | -12 | N/A | -8 | N/A |
| 9/30/2017 | 5 | -13 | N/A | -7 | N/A |
| 6/30/2017 | 5 | -12 | N/A | -9 | N/A |
| 3/31/2017 | 4 | -13 | N/A | -9 | N/A |
| 12/31/2016 | 4 | -13 | N/A | -9 | N/A |
| 9/30/2016 | 4 | -12 | N/A | -10 | N/A |
| 6/30/2016 | 7 | -10 | N/A | -9 | N/A |
| 3/31/2016 | 8 | -9 | N/A | -8 | N/A |
| 12/31/2015 | 9 | -7 | N/A | -7 | N/A |
| 9/30/2015 | 9 | -12 | N/A | -7 | N/A |
| 6/30/2015 | 6 | -13 | N/A | -7 | N/A |
| 3/31/2015 | 4 | -14 | N/A | -8 | N/A |
| 12/31/2014 | 3 | -15 | N/A | -9 | N/A |
| 9/30/2014 | 3 | -13 | N/A | -9 | N/A |
| 6/30/2014 | 3 | -15 | N/A | -8 | N/A |
| 3/31/2014 | 3 | -15 | N/A | -8 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if APDN's forecast earnings growth is above the savings rate (2.6%).
Earnings vs Market: Insufficient data to determine if APDN's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if APDN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if APDN's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if APDN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if APDN's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 23:37 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Applied DNA Sciences, Inc. is covered by 7 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jan Wald | Benchmark Company |
| Matthew Miller | CFRA Equity Research |
| Yi Chen | H.C. Wainwright & Co. |